RE:Palladin/Bionche Licensing AgreementRube, all Bioniche's Agreements with Palladin are now owned by Endo as far as I can determine. In other words, Endo holds the $30M+ debt and all the contractual rights to Urocidin in that agreement ie Canada/Mexico/South Africa.
Another thing we all need to know, is just what the market told us today. Applications are cheap, approvals are worth something. That said, I'm impressed with our Dr. CEO for rolling the ball.......in the right direction, and in a timely manner. The market also is reacting favorably to his moves.